Oscar Health, Inc. (NYSE:OSCR) Shares Acquired by Toth Financial Advisory Corp

Toth Financial Advisory Corp increased its position in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 73,185.7% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 51,300 shares of the company's stock after acquiring an additional 51,230 shares during the quarter. Toth Financial Advisory Corp's holdings in Oscar Health were worth $1,088,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of OSCR. Price T Rowe Associates Inc. MD boosted its holdings in shares of Oscar Health by 153.5% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company's stock valued at $59,156,000 after purchasing an additional 2,409,160 shares during the last quarter. First Light Asset Management LLC boosted its holdings in shares of Oscar Health by 117.3% in the 1st quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company's stock valued at $31,265,000 after purchasing an additional 1,134,919 shares during the last quarter. Renaissance Technologies LLC boosted its holdings in shares of Oscar Health by 31.7% in the 2nd quarter. Renaissance Technologies LLC now owns 3,886,100 shares of the company's stock valued at $61,478,000 after purchasing an additional 934,600 shares during the last quarter. Point72 Asset Management L.P. acquired a new position in shares of Oscar Health in the 2nd quarter valued at $14,716,000. Finally, Bank of New York Mellon Corp boosted its holdings in shares of Oscar Health by 161.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 1,393,048 shares of the company's stock valued at $22,038,000 after purchasing an additional 860,226 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company's stock.

Analysts Set New Price Targets

A number of brokerages have recently commented on OSCR. Piper Sandler reissued an "overweight" rating and issued a $28.00 target price on shares of Oscar Health in a research note on Tuesday, September 10th. UBS Group began coverage on shares of Oscar Health in a research note on Monday, October 7th. They issued a "neutral" rating and a $23.00 target price on the stock. Three analysts have rated the stock with a hold rating, four have assigned a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, Oscar Health currently has a consensus rating of "Moderate Buy" and a consensus price target of $24.00.

Insider Buying and Selling

In related news, CAO Victoria Baltrus sold 4,226 shares of Oscar Health stock in a transaction on Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total transaction of $76,025.74. Following the sale, the chief accounting officer now owns 140,648 shares of the company's stock, valued at $2,530,257.52. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, insider Mario Schlosser sold 3,198 shares of the business's stock in a transaction dated Tuesday, September 3rd. The shares were sold at an average price of $17.99, for a total value of $57,532.02. Following the completion of the sale, the insider now owns 76,982 shares of the company's stock, valued at approximately $1,384,906.18. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CAO Victoria Baltrus sold 4,226 shares of the business's stock in a transaction dated Tuesday, September 3rd. The stock was sold at an average price of $17.99, for a total transaction of $76,025.74. Following the completion of the sale, the chief accounting officer now directly owns 140,648 shares of the company's stock, valued at $2,530,257.52. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 169,569 shares of company stock valued at $3,007,069 in the last quarter. Company insiders own 25.11% of the company's stock.

Oscar Health Stock Down 2.4 %

Oscar Health stock traded down $0.39 during midday trading on Monday, hitting $15.96. 3,600,452 shares of the stock were exchanged, compared to its average volume of 3,212,980. Oscar Health, Inc. has a 1 year low of $4.72 and a 1 year high of $23.79. The firm has a market cap of $3.86 billion, a P/E ratio of -122.76, a P/E/G ratio of 34.83 and a beta of 1.62. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.91 and a quick ratio of 0.91. The company has a 50 day moving average price of $18.96 and a two-hundred day moving average price of $18.32.

Oscar Health (NYSE:OSCR - Get Free Report) last released its quarterly earnings results on Wednesday, August 7th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.16 by $0.04. Oscar Health had a net margin of 0.25% and a return on equity of 1.86%. The firm had revenue of $2.20 billion for the quarter, compared to the consensus estimate of $2.13 billion. During the same quarter in the previous year, the firm posted ($0.07) EPS. The firm's quarterly revenue was up 44.6% on a year-over-year basis. On average, sell-side analysts predict that Oscar Health, Inc. will post 0.01 earnings per share for the current fiscal year.

About Oscar Health

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.